CL7 1.5 mg Pill: yellow , capsule/oblong, 18mm
The pill with imprint CL7 1.5 mg (Yellow, Capsule/Oblong1) has been identified as Rivastigmine Tartrate 1.5 mg and is used for Parkinson's Disease, and Alzheimer's Disease. It belongs to the drug class cholinesterase inhibitors and is not a controlled substance.
Images for CL7 1.5 mg

Rivastigmine Tartrate
- Imprint
- CL7 1.5 mg
- Strength
- 1.5 mg
- Color
- Yellow
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Macleods Pharmaceuticals Limited
- National Drug Code (NDC)
- 33342-0089
- Inactive Ingredients
-
magnesium stearate,
microcrystalline cellulose,
silicon dioxide,
gelatin,
titanium dioxide,
sodium lauryl sulfate,
ferric oxide red,
ferric oxide yellow,
hypromelloses
Note: Inactive ingredients may vary.
See also:
More about rivastigmine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (39)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: cholinesterase inhibitors
Patient resources
- Rivastigmine drug information
- Rivastigmine transdermal
- Rivastigmine (Oral) (Advanced Reading)
- Rivastigmine (Transdermal) (Advanced Reading)
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.